Dear Doctors, Thank you for visiting the Upjohn Pain Academy infocenter and taking a keen interest. We all are aware of the history of COX-2 inhibitors and the concerns about their clinical safety profile.1 Pfizer Upjohn has just launched Celebrex (celecoxib), a selective COX-2 inhibitor.
Please take this two-minute survey to put your current understanding of the topic to test!